Dermama stem cells therapy shows promise for treating leprosy (Hansen's disease). Leprosy remains a serious problem in Indonesia, with over 17,000 new cases reported in 2011 and nearly 2,000 of those in children. Current multidrug treatments have not significantly reduced new cases and access to antibiotics can be limited. Dermama stem cell therapy was able to heal severe, chronic leprosy symptoms and infections within 3 weeks, demonstrating potential as an effective alternative or supplemental treatment to antibiotics.

1. DERMAMA STEM CELLS THERAPY
FOR
LEPROCY (HANSEN’S DISEASE)
A GENERAL VIEW

2. Leprocy ( Hansen’s Disease )
According to Tropical Disease Center, Airlangga University, Surabaya (2011):
• Indonesia has the 3rd biggest leprocy case in the world
• 17,012 new cases of leprocy reported in 2011
• 1,904 leprocy cases are children
Risk of chronic Leprocy:
• Sensory and Motor damage
• Deformities and Disabilities
Effectiveness of current treatment:
– Multidrug regiment  the numer of new leprocy cases remained relatively unchanged
– Access and delivery of antibiotics continue to be a problem
– Lack of an effective vaccine

3. DERMAMA STEM CELLS THERAPY
ON LEPROCY
Chronic Leprocy (30 years of 3 weeks after Dermama Stem Cells
suffering) + Combustion + Severe Therapy
Infection

4. THANK YOU